Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Jawahar Mehta to Myocardial Infarction

This is a "connection" page, showing publications Jawahar Mehta has written about Myocardial Infarction.

 
Connection Strength
 
 
 
5.326
 
  1. Kore RA, Wang X, Ding Z, Griffin RJ, Tackett AJ, Mehta JL. MSC exosome-mediated cardioprotection in ischemic mouse heart comparative proteomics of infarct and peri-infarct areas. Mol Cell Biochem. 2021 Apr; 476(4):1691-1704.
    View in: PubMed
    Score: 0.579
  2. Ding Z, Wang X, Liu S, Shahanawaz J, Theus S, Fan Y, Deng X, Zhou S, Mehta JL. PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy. Cardiovasc Res. 2018 11 01; 114(13):1738-1751.
    View in: PubMed
    Score: 0.497
  3. Wang X, Guo Z, Ding Z, Mehta JL. Inflammation, Autophagy, and Apoptosis After Myocardial Infarction. J Am Heart Assoc. 2018 04 21; 7(9).
    View in: PubMed
    Score: 0.479
  4. Wang X, Ding Z, Yang F, Dai Y, Chen P, Theus S, Singh S, Budhiraja M, Mehta JL. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together. Clin Sci (Lond). 2016 08 01; 130(15):1353-62.
    View in: PubMed
    Score: 0.418
  5. Balamurugan A, Delongchamp R, Im L, Bates J, Mehta JL. Neighborhood and Acute Myocardial Infarction Mortality as Related to the Driving Time to Percutaneous Coronary Intervention-Capable Hospital. J Am Heart Assoc. 2016 Feb 16; 5(2).
    View in: PubMed
    Score: 0.412
  6. Abualsuod A, Rutland JJ, Watts TE, Pandat S, Delongchamp R, Mehta JL. The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction. Cardiovasc Drugs Ther. 2015 Jun; 29(3):265-75.
    View in: PubMed
    Score: 0.392
  7. Dabhadkar KC, Deshmukh AJ, Kulshreshtha A, Badheka AO, Pant S, Mehta JL. National trends in case fatality based on anatomical location of ST elevation myocardial infarction, 1993 - 2010. Int J Cardiol. 2013 Oct 03; 168(3):3017-8.
    View in: PubMed
    Score: 0.340
  8. Dai Y, Khaidakov M, Wang X, Ding Z, Su W, Price E, Palade P, Chen M, Mehta JL. MicroRNAs involved in the regulation of postischemic cardiac fibrosis. Hypertension. 2013 Apr; 61(4):751-6.
    View in: PubMed
    Score: 0.334
  9. Mehta JL, Singla S. Severe obesity and ST-segment elevation myocardial infarction: the evolving challenge. J Am Coll Cardiol. 2012 May 08; 59(19):1731-2; author reply 1732.
    View in: PubMed
    Score: 0.317
  10. Pant S, Deshmukh A, Murugiah K, Kumar G, Sachdeva R, Mehta JL. Assessing the credibility of the "YouTube approach" to health information on acute myocardial infarction. Clin Cardiol. 2012 May; 35(5):281-5.
    View in: PubMed
    Score: 0.315
  11. Mehta JL. Erythropoietin in cardioprotection: does it have a future or is it all in the past? Cardiovasc Res. 2008 Sep 01; 79(4):549-50.
    View in: PubMed
    Score: 0.243
  12. Eigenbrodt ML, Sukhija R, Rose KM, Tracy RE, Couper DJ, Evans GW, Bursac Z, Mehta JL. Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study. Cardiovasc Ultrasound. 2007 Mar 09; 5:11.
    View in: PubMed
    Score: 0.222
  13. Novelli G, Borgiani P, Mango R, Romeo F, Mehta JL. OLR1 gene and coronary artery disease/acute myocardial infarction: replication in an independently collected sample. Eur J Hum Genet. 2006 Aug; 14(8):894-5; author reply 895.
    View in: PubMed
    Score: 0.210
  14. Aude YW, Mehta JL. Do we need continuous ECG monitoring in patients transferred for primary angioplasty? Eur Heart J. 2006 Feb; 27(3):249-50.
    View in: PubMed
    Score: 0.203
  15. Galanzha EI, Sarimollaoglu M, Nedosekin DA, Keyrouz SG, Mehta JL, Zharov VP. In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrasts. Cytometry A. 2011 Oct; 79(10):814-24.
    View in: PubMed
    Score: 0.075
  16. Sukhija R, Aronow WS, Sureddi R, Aleti S, Molavi B, Sachdeva R, Mehta JL. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus. Am J Cardiol. 2007 Sep 01; 100(5):777-80.
    View in: PubMed
    Score: 0.056
  17. Sukhija R, Fahdi I, Garza L, Fink L, Scott M, Aude W, Pacheco R, Bursac Z, Grant A, Mehta JL. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol. 2007 Apr 01; 99(7):879-84.
    View in: PubMed
    Score: 0.055
  18. Mango R, Biocca S, del Vecchio F, Clementi F, Sangiuolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli C, Lauro R, Mehta JL, Romeo F, Novelli G. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res. 2005 Jul 22; 97(2):152-8.
    View in: PubMed
    Score: 0.049
  19. Schr?r K, Mehta P, Mehta JL. Cardiovascular risk of selective cyclooxygenase-2 inhibitors. J Cardiovasc Pharmacol Ther. 2005 Jun; 10(2):95-101.
    View in: PubMed
    Score: 0.049
  20. Chen H, Li D, Saldeen T, Mehta JL. TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol. 2003 May; 284(5):H1612-7.
    View in: PubMed
    Score: 0.042
  21. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. Am Heart J. 2021 02; 232:10-22.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.